Laurus Labs steps up focus on R&D with a pipeline of 60 products
Laurus Labs has stepped up its focus on Research and Development (R&D) with a pipeline of 60 products, according to its founder and Chief Executive...
Continue ReadingUSFDA concludes inspection of Cipla unit’s manufacturing facility with zero observations
Cipla Ltd. said that the United States Food and Drug Administration (USFDA) recently completed an inspection at the manufacturing facility of the company’s arm InvaGen...
Continue ReadingPharmexcil upbeat on export growth prospects in South Korea, inks MoU with KPBMA
South Korea with its focus on providing universal health coverage, for the people, and emphasis on cost containment measures is poised to emerge as a...
Continue ReadingSerum arm to double investment in Biocon unit
Serum Life Sciences, a unit of India’s largest vaccine maker, would pick up an additional stake in Biocon Biologics “through the conversion of the $150...
Continue ReadingDr Reddy’s ropes in Sonu Sood as brand ambassador for Rebalanz Vitors
Dr Reddy’s Laboratories has roped in fitness enthusiast, actor, and philanthropist, Sonu Sood as its brand ambassador for Rebalanz Vitors.Launched in 2018 in the ready-to-serve...
Continue ReadingEnzene Biosciences raises $50 million to expand ops in India, US markets
Biotech company Enzene Biosciences, a subsidiary of Mumbai-based drug maker Alkem Laboratories, has raised $50 million (or roughly Rs 408 crore) in fresh equity funding...
Continue ReadingIndian pharma firm’s first-of-its-kind AIDS drug for children gets FDA approval
Hyderabad-based pharmaceutical firm Laurus Labs has received in-principle approval from the United States Food and Drugs Administrator (FDA) to launch the world’s first Oral Dispersible...
Continue ReadingBiocon Biologics wins the ‘ABEA : Bioprocessing Excellence in South Asia’ award
Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, announced that it has won the prestigious ‘Bioprocessing Excellence in South Asia’ Award at the Asia-Pacific...
Continue ReadingLupin gets tentative USFDA approval to market generic valbenazine capsules
Pharmaceuticals firm Lupin Ltd. said it has received tentative approval from the U.S. health regulator to market its generic valbenazine capsules used to treat involuntary...
Continue Reading